October 2, 2020October 2, 2020

Phase 3 Trial Testing Brensocatib for Bronchiectasis Set to Start Soon

News

A global Phase 3 clinical trial of brensocatib in people with non-cystic fibrosis (CF) bronchiectasis is expected to launch by the end of this year, according to the treatment’s developer Insmed. ... Read more

September 14, 2020September 14, 2020

Brensocatib Significantly Lowers Flare Risk in Non-CF Bronchiectasis, Trial Shows

News

Treatment with brensocatib significantly and safely extended the time to a first exacerbation and lowered flare rates in people with non-cystic fibrosis bronchiectasis (NCFBE), results from a Phase 2 trial show. ... Read more